Hsp90-mediated inhibition of FKBP38 regulates apoptosis in neuroblastoma cells.
The FK506-binding protein 38 (FKBP38) is a pro-apoptotic regulator of Bcl-2 in neuroblastoma cells. Hsp90 inhibits the pro-apoptotic FKBP38/CaM/Ca(2+) complex and thus prevents interactions between FKBP38 and Bcl-2. Here we show that Hsp90 increases cell survival rates of neuroblastoma cells after apoptosis induction. Depletion of FKBP38 by short interference RNA significantly decreased the anti-apoptotic effect of Hsp90 expression. In addition, the influence of high cellular Hsp90 levels was only observed in post-stimulation apoptosis that is sensitive to selective FKBP38 active site inhibition. Similar anti-apoptotic effects in neuroblastoma cells were observed after stimulation of endogenous Hsp90 expression. Hence, the inhibition of FKBP38 by Hsp90 participates in programmed cell death control of neuroblastoma cells.
Erdmann
Frank
F
Max-Planck Research Unit for Enzymology of Protein Folding, Weinbergweg 22, D-06120, Halle/Saale, Germany.
Jarczowski
Franziska
F
Weiwad
Matthias
M
Fischer
Gunter
G
Edlich
Frank
F
D017209:Apoptosis; D001665:Binding Sites; D002118:Calcium / Q000378:metabolism; D002147:Calmodulin / Q000378:metabolism; D016923:Cell Death; D045744:Cell Line, Tumor; D018841:HSP90 Heat-Shock Proteins / Q000378:metabolism*; D006801:Humans; D019807:Iodoacetic Acid / Q000494:pharmacology; D009447:Neuroblastoma / Q000378:metabolism*; D022021:Tacrolimus Binding Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism
D002147:Calmodulin; D018841:HSP90 Heat-Shock Proteins; D022021:Tacrolimus Binding Proteins; D002118:Calcium; D019807:Iodoacetic Acid